FN1 and chronic myelogenous leukemia, BCR-ABL1 positive: Our data indicate that FN1 deregulation is a recurrent phenomenon of TKI-resistant CML, both in vitro and in a clinical setting, as FN1 mRNA was absent in TKI-resistant cell lines and dysregulated in peripheral blood cells from CML patients.